Search Results - "Vilaseca, M A"

Refine Results
  1. 1

    Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas by Sarrión, P., Sangorrin, A., Urreizti, R., Delgado, A., Artuch, R., Martorell, L., Armstrong, J., Anton, J., Torner, F., Vilaseca, M. A., Nevado, J., Lapunzina, P., Asteggiano, C. G., Balcells, S., Grinberg, D.

    Published in Scientific reports (26-02-2013)
    “…Multiple osteochondromas is an autosomal dominant skeletal disorder characterized by the formation of multiple cartilage-capped tumours. Two causal genes have…”
    Get full text
    Journal Article
  2. 2

    Mutational study in the PDHA1 gene of 40 patients suspected of pyruvate dehydrogenase complex deficiency by Quintana, E, Gort, L, Busquets, C, Navarro-Sastre, A, Lissens, W, Moliner, S, Lluch, M, Vilaseca, MA, De Meirleir, L, Ribes, A, Briones, P

    Published in Clinical genetics (01-05-2010)
    “…Quintana E, Gort L, Busquets C, Navarro‐Sastre A, Lissens W, Moliner S, Lluch M, Vilaseca MA, De Meirleir L, Ribes A, Briones P, PDH Working Group. Mutational…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Arginine supplementation in four patients with X-linked creatine transporter defect by Fons, C, Sempere, A, Arias, A, López-Sala, A, Póo, P, Pineda, M, Mas, A, Vilaseca, M. A, Salomons, G. S, Ribes, A, Artuch, R, Campistol, J

    Published in Journal of inherited metabolic disease (01-12-2008)
    “…Background Treatment with oral creatine monohydrate has not shown efficacy in patients with creatine transporter deficiency (CRTR-D). Another therapeutic…”
    Get full text
    Journal Article
  5. 5

    X‐Linked creatine transporter deficiency in two patients with severe mental retardation and autism by Póo‐Argüelles, P., Arias, A., Vilaseca, M. A., Ribes, A., Artuch, R., Sans‐Fito, A., Moreno, A., Jakobs, C., Salomons, G.

    Published in Journal of inherited metabolic disease (01-02-2006)
    “…Summary We describe the first two unrelated Spanish patients with creatine transporter deficiency initially identified by brain proton magnetic resonance…”
    Get full text
    Journal Article
  6. 6

    Global and regional volume changes in the brains of patients with phenylketonuria by PEREZ-DUENAS, B, PUJOL, J, SORIANO-MAS, C, ORTIZ, H, ARTUCH, R, VILASECA, M. A, CAMPISTOL, J

    Published in Neurology (11-04-2006)
    “…Although phenylketonuria is a treatable disease, patients with late or nonoptimal phenylalanine-restricted diet may experience brain damage. The authors used…”
    Get full text
    Journal Article
  7. 7

    Molecular characterization of five patients with homocystinuria due to severe methylenetetrahydrofolate reductase deficiency by Urreizti, R, Moya-García, AA, Pino-Ángeles, A, Cozar, M, Langkilde, A, Fanhoe, U, Esteves, C, Arribas, J, Vilaseca, MA, Pérez-Dueñas, B, Pineda, M, González, V, Artuch, R, Baldellou, A, Vilarinho, L, Fowler, B, Ribes, A, Sánchez-Jiménez, F, Grinberg, D, Balcells, S

    Published in Clinical genetics (01-11-2010)
    “…Urreizti R, Moya‐García AA, Pino‐ Ángeles A, Cozar M, Langkilde A, Fanhoe U, Esteves C, Arribas J, Vilaseca MA, Pérez‐Dueñas B, Pineda M, González V, Artuch R,…”
    Get full text
    Journal Article
  8. 8

    Mutations in the urocanase gene UROC1 are associated with urocanic aciduria by Espinós, C, Pineda, M, Martínez-Rubio, D, Lupo, V, Ormazabal, A, Vilaseca, M A, Spaapen, L J M, Palau, F, Artuch, R

    Published in Journal of medical genetics (01-06-2009)
    “…Urocanase is an enzyme in the histidine pathway encoded by the UROC1 gene. This report describes the first putative mutations, p.L70P and p.R450C, in the…”
    Get more information
    Journal Article
  9. 9

    Ancient origin of the CTH alelle carrying the c.200C>T (p.T67I) variant in patients with cystathioninuria by Espinós, C, García-Cazorla, A, Martínez-Rubio, D, Martínez-Martínez, E, Vilaseca, MA, Pérez-Dueñas, B, Kožich, V, Palau, F, Artuch, R

    Published in Clinical genetics (01-12-2010)
    “…Espinós C, García‐Cazorla A, Martínez‐Rubio D, Martínez‐Martínez E, Vilaseca MA, Pérez‐Dueñas B, Kožich V, Palau F, Artuch R. Ancient origin of the CTH alelle…”
    Get full text
    Journal Article
  10. 10

    Assessment of plasma ammonia and glutamine concentrations in urea cycle disorders by Serrano, M., Ormazábal, A., Vilaseca, M.A., Lambruschini, N., Garcia-Romero, R., Meavilla, S., Perez-Dueñas, B., Pineda, M., Garcia-Cazorla, A., Campistol, J., Artuch, R.

    Published in Clinical biochemistry (01-06-2011)
    “…To analyze the association between ammonia and glutamine used for metabolic control in inherited urea cycle disorders (UCD) in a large series of patients…”
    Get full text
    Journal Article
  11. 11

    Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid by Ormazabal, A, Artuch, R, Vilaseca, M A, Aracil, A, Pineda, M

    Published in Neuropediatrics (01-12-2005)
    “…Previous studies in Rett syndrome (RS) patients suggested various abnormalities in biogenic amines, pterins, and folate values in cerebrospinal fluid (CSF)…”
    Get more information
    Journal Article
  12. 12

    Response to creatine analogs in fibroblasts and patients with creatine transporter deficiency by Fons, C., Arias, A., Sempere, A., Póo, P., Pineda, M., Mas, A., López-Sala, A., Garcia-Villoria, J., Vilaseca, M.A., Ozaez, L., Lluch, M., Artuch, R., Campistol, J., Ribes, A.

    Published in Molecular genetics and metabolism (01-03-2010)
    “…Creatine transporter (CRTR) deficiency is one of the most frequent causes of X-linked mental retardation. The lack of an effective treatment for this disease,…”
    Get full text
    Journal Article
  13. 13

    Long-term evolution of eight Spanish patients with CDG type Ia: Typical and atypical manifestations by Pérez-Dueñas, B, García-Cazorla, A, Pineda, M, Poo, P, Campistol, J, Cusí, V, Schollen, E, Matthijs, G, Grunewald, S, Briones, P, Pérez-Cerdá, C, Artuch, R, Vilaseca, M.A

    Published in European journal of paediatric neurology (01-09-2009)
    “…Abstract Congenital disorder of glycosylation Ia (CDG-Ia) is a metabolic disease with a broad spectrum of clinical signs, including recently described mild…”
    Get full text
    Journal Article
  14. 14

    Plasma amino acids in anorexia nervosa by MOYANO, D, VILASECA, M. A, ARTUCH, R, LAMBRUSCHINI, N

    Published in European journal of clinical nutrition (01-09-1998)
    “…To evaluate the amino acid profile in a group of adolescents with anorexia nervosa, and to apply alternative ways of presenting and assessing results, so as to…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Biochemical and molecular studies in 26 Spanish patients with congenital disorder of glycosylation type Ia by Briones, P., Vilaseca, M. A., Schollen, E., Ferrer, I., Maties, M., Busquets, C., Artuch, R., Gort, L., Marco, M., Schaftingen, E., Matthijs, G., Jaeken, J., Chabás, A.

    Published in Journal of inherited metabolic disease (01-02-2003)
    “…We present our experience with the diagnosis of 26 patients (19 families) with congenital disorders of glycosylation classified as type Ia due toPMM…”
    Get full text
    Journal Article
  18. 18

    Platelet serotonin concentrations in PKU patients under dietary control and tetrahydrobiopterin treatment by Ormazabal, A., Vilaseca, M. A., Pérez‐Dueñas, B., Lambruschini, N., Gómez, L., Campistol, J., Artuch, R.

    Published in Journal of inherited metabolic disease (01-12-2005)
    “…Summary Tetrahydrobiopterin (BH4) supplementation has been applied in PKU treatment, resulting in successful control of blood phenylalanine (Phe)…”
    Get full text
    Journal Article
  19. 19

    CblE type of homocystinuria: Mild clinical phenotype in two patients homozygous for a novel mutation in the MTRR gene by Vilaseca, M. A., Vilarinho, L., Zavadakova, P., Vela, E., Cleto, E., Pineda, M., Coimbra, E., Suormala, T., Fowler, B., Kozich, V.

    Published in Journal of inherited metabolic disease (01-01-2003)
    “…Patients with the cblE type of homocystinuria usually present with megaloblastic anaemia, feeding difficulties, developmental delay and cerebral atrophy. We…”
    Get full text
    Journal Article
  20. 20

    Plasma thiols and their determinants in phenylketonuria by COLOME, C, ARTUCH, R, SIERRA, C, BRANDI, N, LAMBRUSCHINI, N, CAMPISTOL, J, VILASECA, M.-A

    Published in European journal of clinical nutrition (01-08-2003)
    “…Treatment of phenylketonuria (PKU) patients consists of a phenylalanine-restricted diet supplemented with a tyrosine-, vitamin- and oligoelement-enriched…”
    Get full text
    Journal Article